Pro Share Advisors LLC Alx Oncology Holdings Inc Transaction History

Pro Share Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$13.65 - $22.06 $130,753 - $211,312	-9,579 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$21.49 - $74.4 $28,259 - $97,836	-1,315 Reduced 12.07%	9,579 $205,000
Q3 2021 Nov 12, 2021	SELL	$52.51 - $80.91 $49,044 - $75,569	-934 Reduced 7.9%	10,894 $805,000
Q2 2021 Aug 13, 2021	BUY	$52.2 - $75.23 $86,913 - $125,257	1,665 Added 16.38%	11,828 $647,000
Q1 2021 May 14, 2021	BUY	$62.84 - $87.68 $143,149 - $199,735	2,278 Added 28.89%	10,163 $749,000
Q4 2020 Feb 09, 2021	BUY	$34.11 - $112.26 $268,957 - $885,170	7,885 New	7,885 $680,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $68.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.